233 related articles for article (PubMed ID: 10839208)
1. Anti-diabetic and toxic effects of vanadium compounds.
Srivastava AK
Mol Cell Biochem; 2000 Mar; 206(1-2):177-82. PubMed ID: 10839208
[TBL] [Abstract][Full Text] [Related]
2. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
[TBL] [Abstract][Full Text] [Related]
3. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
4. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
5. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.
Domingo JL; Gomez M; Sanchez DJ; Llobet JM; Keen CL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):233-40. PubMed ID: 8927043
[TBL] [Abstract][Full Text] [Related]
6. [Comparative characteristics of vanadium-containing compounds, possessing insulin-like effects].
Golubev MA; Gorodetskiĭ VK; Anis'kina AP; Tochilkin AI; Beliaeva NF
Vopr Med Khim; 2000; 46(2):155-61. PubMed ID: 10885036
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
[TBL] [Abstract][Full Text] [Related]
8. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
Domingo JL; Gómez M
Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like effects of vanadium: basic and clinical implications.
Goldwaser I; Gefel D; Gershonov E; Fridkin M; Shechter Y
J Inorg Biochem; 2000 May; 80(1-2):21-5. PubMed ID: 10885459
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
11. [Insulin-mimetic property of vanadium compounds].
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
[TBL] [Abstract][Full Text] [Related]
12. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Goc A; Turyna B; Kordowiak AM
Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds.
Niu X; Xiao R; Wang N; Wang Z; Zhang Y; Xia Q; Yang X
Curr Top Med Chem; 2016; 16(8):811-22. PubMed ID: 26311429
[TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
16. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review.
Scior T; Guevara-García A; Bernard P; Do QT; Domeyer D; Laufer S
Mini Rev Med Chem; 2005 Nov; 5(11):995-1008. PubMed ID: 16307529
[TBL] [Abstract][Full Text] [Related]
17. Effects of vanadium complexes supplementation on V, Fe, Cu, Zn, Mn, Ca and K concentration in STZ diabetic rat's spleen.
Krośniak M; Francik R; Kowalska J; Gryboś R; Blusz M; Kwiatek WM
Acta Pol Pharm; 2013; 70(1):71-7. PubMed ID: 23610961
[TBL] [Abstract][Full Text] [Related]
18. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
19. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
20. Potential use of vanadium compounds in therapeutics.
Barrio DA; Etcheverry SB
Curr Med Chem; 2010; 17(31):3632-42. PubMed ID: 20846114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
